Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

PTCTPTCT
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in PTC THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 4.1M shares of PTCT (PTC THERAPEUTICS INC), worth $336.7M as of 2026-Q2. The position was increased (+4.7% shares). PTCT represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$336.7M

Current Shares

4.1M

Total Value Change

+$43.9M

Total Shares Change

-3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.1M
+4.7%
$336.7M0.1%$81.57
33
2026-Q1
Increased
3.9M
+1.9%
$268.6M0.1%$64.39
31
2025-Q4
Decreased
3.9M
-21.4%
$293.8M0.1%$76.19
0
2025-Q3
Increased
4.9M
+4.8%
$301.9M0.1%$60.65
32
2025-Q2
Decreased
4.7M
-13.4%
$229.3M0.0%$49.84
0
2025-Q1
Increased
5.4M
+13.2%
$276.2M0.1%$54.24
35
2024-Q4
Decreased
4.8M
-39.4%
$216.1M0.0%$45.77
0
2024-Q3
Decreased
7.9M
-3.9%
$292.8M0.1%$37.56
0

Other major holders of PTCT: BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used